AI assistant
Sending…
PTC THERAPEUTICS, INC. — Director's Dealing 2014
Aug 1, 2014
31046_dirs_2014-08-01_89df6f7f-ea45-42e5-8e8e-3415eaee77ad.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: PTC THERAPEUTICS, INC. (PTCT)
CIK: 0001070081
Period of Report: 2014-07-31
Reporting Person: ZELDIS JEROME B (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2014-07-31 | Stock Option (right to buy) | $26.42 | A | 20000 | Acquired | 2024-07-31 | Common Stock (20000) | Direct |
Footnotes
F1: This option award vests over three years in equal increments upon each anniversary of the date of grant.
More from PTC THERAPEUTICS, INC.
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 5
Interim / Quarterly Report
2026
May 7
Investor Presentation
2026
Apr 28
Major Shareholding Notification
2026
Mar 27
Director's Dealing
2026
Mar 27
Director's Dealing
2026
Mar 27
Board/Management Information
2026
Mar 25
Director's Dealing
2026
Feb 23
Director's Dealing
2026
Feb 20
Director's Dealing
2026
Feb 20